MedTrace Logo

Optimal Implementation of Antimicrobial Stewardship in General Practice

NCT06953804 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-05-12

No results posted yet for this study

Summary

This trial aims to increase the use of antimicrobial stewardship resources when treating patients with respiratory tract infections. This trial is set in Australian general practices (family medicine or primary care).

The main question it aims to answer is which type of implementation activities increase the use of antimicrobial stewardship resources. Researchers will compare doctors who receive face-to-face implementation activities (the Integrated Network group) to those who received virtual or online activities (the Virtual Network group). The primary hypothesis is that there will be a difference in how often interventions are used

Participating doctors will be asked to record how often they use antimicrobial stewardship resources and which interventions they prefer. Participating practices will also provide researchers data on how many patients the doctors see.

Patients with respiratory tract infections who saw a participating doctor will be asked to give feedback on their experience using surveys. A subgroup of doctors, practice staff, and patients will interviewed about their experience in the study.

Conditions

  • The Use of Antimicrobial Stewardship in in General Practice (Family Medicine)
  • Respiratory Tract Infections (RTI)

Interventions

OTHER

Antimicrobial stewardship activities delivered through Virtual Network

Participants will receive online self-paced education modules regarding antimicrobial interventions, guided self-audit and reflection regarding intervention use, and reinforcement podcasts (\~7 hours). Participants in the Virtual Newtwork arm will primarily receive these interventions online.

OTHER

Antimicrobial stewardship activities delivered through Integrated Network activities

Participants will receive online self-paced education modules regarding antimicrobial interventions, guided self-audit and reflection regarding intervention use, and reinforcement podcasts (\~7 hours). Participants in the Integrated Network arm will primarily receive these interventions face-to-face and active online activities.

Sponsors & Collaborators

  • University of Wollongong

    lead OTHER

Principal Investigators

  • Andrew Bonney, PhD, · Graduate School of Medicine, University of Wollongong

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2027-11-30
Completion
2028-06-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06953804 on ClinicalTrials.gov